These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exosomes for targeted siRNA delivery across biological barriers. El Andaloussi S; Lakhal S; Mäger I; Wood MJ Adv Drug Deliv Rev; 2013 Mar; 65(3):391-7. PubMed ID: 22921840 [TBL] [Abstract][Full Text] [Related]
3. Natural Carriers for siRNA Delivery. Karunaratne DN; Jafari M; Ranatunga RJ; Siriwardhana A Curr Pharm Des; 2015; 21(31):4529-40. PubMed ID: 26486140 [TBL] [Abstract][Full Text] [Related]
4. Exosomes: Therapy delivery tools and biomarkers of diseases. Barile L; Vassalli G Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367 [TBL] [Abstract][Full Text] [Related]
5. Targeted si-RNA with liposomes and exosomes (extracellular vesicles): How to unlock the potential. Antimisiaris S; Mourtas S; Papadia K Int J Pharm; 2017 Jun; 525(2):293-312. PubMed ID: 28163221 [TBL] [Abstract][Full Text] [Related]
6. Comparing exosome-like vesicles with liposomes for the functional cellular delivery of small RNAs. Stremersch S; Vandenbroucke RE; Van Wonterghem E; Hendrix A; De Smedt SC; Raemdonck K J Control Release; 2016 Jun; 232():51-61. PubMed ID: 27072025 [TBL] [Abstract][Full Text] [Related]
7. Exosomes from iPSCs Delivering siRNA Attenuate Intracellular Adhesion Molecule-1 Expression and Neutrophils Adhesion in Pulmonary Microvascular Endothelial Cells. Ju Z; Ma J; Wang C; Yu J; Qiao Y; Hei F Inflammation; 2017 Apr; 40(2):486-496. PubMed ID: 28000095 [TBL] [Abstract][Full Text] [Related]
9. Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Shtam TA; Kovalev RA; Varfolomeeva EY; Makarov EM; Kil YV; Filatov MV Cell Commun Signal; 2013 Nov; 11():88. PubMed ID: 24245560 [TBL] [Abstract][Full Text] [Related]
10. Delivering siRNA with Dendrimers: In Vivo Applications. Leiro V; Santos SD; Pego AP Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741 [TBL] [Abstract][Full Text] [Related]
11. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Wahlgren J; De L Karlson T; Brisslert M; Vaziri Sani F; Telemo E; Sunnerhagen P; Valadi H Nucleic Acids Res; 2012 Sep; 40(17):e130. PubMed ID: 22618874 [TBL] [Abstract][Full Text] [Related]
12. Exosomes: natural nanoparticles as bio shuttles for RNAi delivery. Darband SG; Mirza-Aghazadeh-Attari M; Kaviani M; Mihanfar A; Sadighparvar S; Yousefi B; Majidinia M J Control Release; 2018 Nov; 289():158-170. PubMed ID: 30290245 [TBL] [Abstract][Full Text] [Related]
13. Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine. Koppers-Lalic D; Hogenboom MM; Middeldorp JM; Pegtel DM Adv Drug Deliv Rev; 2013 Mar; 65(3):348-56. PubMed ID: 22820525 [TBL] [Abstract][Full Text] [Related]
14. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. Kooijmans SAA; Stremersch S; Braeckmans K; de Smedt SC; Hendrix A; Wood MJA; Schiffelers RM; Raemdonck K; Vader P J Control Release; 2013 Nov; 172(1):229-238. PubMed ID: 23994516 [TBL] [Abstract][Full Text] [Related]
15. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer. Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487 [TBL] [Abstract][Full Text] [Related]
16. Exosomes in diagnostic and therapeutic applications: biomarker, vaccine and RNA interference delivery vehicle. Lässer C Expert Opin Biol Ther; 2015 Jan; 15(1):103-17. PubMed ID: 25363342 [TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of endothelial exosomes as carriers for small interfering ribonucleic acid delivery. Banizs AB; Huang T; Dryden K; Berr SS; Stone JR; Nakamoto RK; Shi W; He J Int J Nanomedicine; 2014; 9():4223-30. PubMed ID: 25214786 [TBL] [Abstract][Full Text] [Related]
18. Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse. Liu Y; Li D; Liu Z; Zhou Y; Chu D; Li X; Jiang X; Hou D; Chen X; Chen Y; Yang Z; Jin L; Jiang W; Tian C; Zhou G; Zen K; Zhang J; Zhang Y; Li J; Zhang CY Sci Rep; 2015 Dec; 5():17543. PubMed ID: 26633001 [TBL] [Abstract][Full Text] [Related]
19. Conjugates of small targeting molecules to non-viral vectors for the mediation of siRNA. Zhi D; Zhao Y; Cui S; Chen H; Zhang S Acta Biomater; 2016 May; 36():21-41. PubMed ID: 27045350 [TBL] [Abstract][Full Text] [Related]
20. Advances in the development of siRNA-based therapeutics for cancer. Shen Y IDrugs; 2008 Aug; 11(8):572-8. PubMed ID: 18683092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]